Sabra Healthcare REIT

SBRA

Market cap $5.13B

TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #1Q26--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that it will issue its 2026 first quarter earnings release on April 29, 2026, after the close of trading. A conference call with a simultaneous webcast to discuss the 2026 first quarter results will be held on Thursday, April 30th at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference ID.

Oil is up, and everything else is down. Stocks. Bonds.

TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #SBRA--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the company's Chair and Chief Executive Officer, Darrin Smith, the company's Chief Investment Officer, Eliza Gozar, the company's Senior Vice President of Investments, and other members of the company, will attend the 2026 NIC Spring Conference on March 30 – April 1, 2026, at the Omni Nashville Hotel in Nashville, Tennessee. About Sabra Sabra Health Care REIT, Inc., a Maryland corporat.

Engineers Gate Manager LP sold 1,513,777 shares of Sabra Health Care REIT (SBRA) Quarter-end position value decreased by $26.85 million, reflecting both trading and price movement effects Transaction represented a 0.33% change in fund's 13F assets under management Post-trade, the fund holds 4,544,219 shares valued at $86.07 million The position now accounts for 1.02% of 13F AUM, placing it outside the fund's top five holdings

TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #DBSummit--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the company's Chair and Chief Executive Officer, Michael Costa, the company's Chief Financial Officer, Darrin Smith, the company's Chief Investment Officer, and Lukas Hartwich, the company's Executive Vice President of Finance, will participate in Deutsche Bank's 2026 Healthcare REIT Summit virtually on March 24, 2026. About Sabra Sabra Health Care REIT, Inc., a Maryland corporation, o.

Sabra Health Care remains a Buy, supported by strong SHOP expansion, robust guidance, and a sustainable 5.84% dividend yield. SBRA projects 4.9%-5.4% FFO growth and plans over $450 million in investments for 2026, with a solid pipeline and a good debt schedule. Leverage is steady at 5x, with recent refinancing extending maturities and reducing interest costs, supporting financial flexibility.

Sabra Health Care REIT, Inc. (SBRA) Q4 2025 Earnings Call Transcript

TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #CITI--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the company's Chair and Chief Executive Officer; Michael Costa, the company's Chief Financial Officer; Darrin Smith, the company's Chief Investment Officer; and Lukas Hartwich, the company's Executive Vice President of Finance, will attend Citi's 2026 Global Property CEO Conference on March 1-4, 2026, at The Diplomat Beach Resort in Hollywood, Florida. About Sabra Sabra Health Care REI.

TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #4Q25--Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced its results of operations for the fourth quarter of 2025. FOURTH QUARTER 2025 RESULTS AND RECENT EVENTS Results per diluted common share for the fourth quarter of 2025 were as follows: Net Income: $0.11 FFO: $0.36 Normalized FFO: $0.36 AFFO: $0.37 Normalized AFFO: $0.38 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 2.38x Senior Housing - Leased: 1.52x Beh.

NAV Monitor: U.S. REITs End January At Median 16.2% Discount To Net Asset Value